|
Volumn 72, Issue 3, 2008, Pages 719-720
|
Re: Zhao et al.: External Validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment Score (Urology 2008;72:396-400)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
PROSTATE SPECIFIC ANTIGEN;
ACCURACY;
CANCER MORTALITY;
CANCER RECURRENCE;
CANCER RISK;
CANCER STAGING;
EXTERNAL VALIDITY;
GLEASON SCORE;
HOSPITAL PHYSICIAN;
HUMAN;
LETTER;
LONGEVITY;
MEDICAL DECISION MAKING;
MEDICAL INSTRUMENTATION;
NOMOGRAM;
PATIENT CARE;
PRIORITY JOURNAL;
PROGNOSIS;
PROSTATE CANCER;
PROSTATECTOMY;
RISK ASSESSMENT;
TREATMENT OUTCOME;
UNIVERSITY HOSPITAL;
CALIFORNIA;
DATA INTERPRETATION, STATISTICAL;
HUMANS;
MALE;
MULTIVARIATE ANALYSIS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATECTOMY;
PROSTATIC NEOPLASMS;
REPRODUCIBILITY OF RESULTS;
RISK ASSESSMENT;
RISK FACTORS;
|
EID: 50249129829
PISSN: 00904295
EISSN: 15279995
Source Type: Journal
DOI: 10.1016/j.urology.2008.01.039 Document Type: Letter |
Times cited : (1)
|
References (5)
|